AOTMiT: Transparency Council, among others, on rehabilitation program for cancer patients

During the session, it was planned:

1. Preparation of a position paper on the evaluation of the drug Cosentyx (secukinumabum) under the drug program "Treatment of patients with suppurative apocrine sweat gland (HS) inflammation (ICD-10: L 73.2)".
2. Preparation of a position paper on the evaluation of the medicinal product ARIKAYCE liposomal, amikacini sulfas for the indication: pulmonary mycobacteriosis.
3. Preparation of an opinion on the health policy program of the local government unit "Program of comprehensive protection of procreative health for residents of the Lodz region".
4. Preparation of an opinion on the health policy program of the local government unit "Rehabilitation program for oncology patients aged 18-64 from the territory of the Wielkopolska province".

Source: AOTMiT